España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
GSK
GSK
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Q4 2024 Earnings in 7 days from now on Wed Feb 5th, before the market open
Conference call scheduled in 7 days at 5:45 AM
Click to view the webcast
GSK (GSK) Forecast
News
Earnings
GSK (GSK) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for GSK (NYSE:GSK) Stock
GSK Stock (NYSE: GSK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 29, 2025
Trump Health Sec Nominee Kennedy Says He Will...
Benzinga Newsdesk
Tuesday, January 28, 2025
The European Medicines Agency Has Accepted Fo...
Benzinga Newsdesk
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?
Kaustubh Bagalkote
Monday, January 27, 2025
GSK shares are trading higher after the compa...
Benzinga Newsdesk
The European Medicines Agency Has Accepted Fo...
Benzinga Newsdesk
Friday, January 24, 2025
Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads
Erica Kollmann
Tuesday, January 21, 2025
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
Erica Kollmann
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer
Vandana Singh
Friday, January 17, 2025
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Anthony Noto
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Vandana Singh
'Ozempic Is In The Next Round Of Medicare Dru...
Benzinga Newsdesk
Thursday, January 16, 2025
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing
Erica Kollmann
'As Bird Flu Affects More People And Animals,...
Benzinga Newsdesk
Wednesday, January 15, 2025
GSK Highlights New Approvals, Vaccine Momentum At JPMorgan Healthcare Conference
Vandana Singh
Monday, January 13, 2025
GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion
Vandana Singh
Illumina Launches Proteomics Pilot with 50,00...
Benzinga Newsdesk
GSK To Acquire Biopharma Firm IDRx for $1B An...
Benzinga Newsdesk
Friday, January 10, 2025
Why CureVac (CVAC) Shares Are Volatile
Henry Khederian
The FDA Has Accepted For Review GSK's Regulat...
Benzinga Newsdesk
Wednesday, January 08, 2025
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Chandrima Sanyal
'GSK nears $1B deal for biotech developing dr...
Benzinga Newsdesk
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder
Vandana Singh
Tuesday, January 07, 2025
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Erica Kollmann
Monday, January 06, 2025
'LDH Reports First U.S. H5N1-Related Human De...
Benzinga Newsdesk
Friday, January 03, 2025
GSK's Sinus Disease Drug Secures Approval In China
Vandana Singh
The China National Medical Products Administr...
Benzinga Newsdesk
Monday, December 23, 2024
Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst Conviction
Anusuya Lahiri
Friday, December 20, 2024
GSK Announced Headline Results From FIRST-ENG...
Benzinga Newsdesk
Thursday, December 19, 2024
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Vandana Singh
Wednesday, December 18, 2024
CA Governor Newsom Proclaimed State Of Emerge...
Benzinga Newsdesk
CDC Confirms First Severe Case Of H5N1 Bird F...
Benzinga Newsdesk
Monday, December 16, 2024
What's Going On With Moderna Stock On Monday?
Vandana Singh
GSK Announces The U.S. FDA Has Granted Breakt...
Benzinga Newsdesk
The Committee For Medicinal Products For Huma...
Benzinga Newsdesk
Friday, December 13, 2024
Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children
Maureen Meehan
Bird Flu Spreads To Cats, Possibly Horses As Officials Signal No Plans To Authorize Vaccination
Hayden Buckfire
United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis
Vandana Singh
Thursday, December 12, 2024
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
Vandana Singh
Tuesday, December 10, 2024
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
Vandana Singh
Monday, December 09, 2024
GSK shares are trading higher. GSK's DREAMM-7...
Benzinga Newsdesk
GSK's DREAMM-7 Trial Shows Sustained Overall ...
Benzinga Newsdesk
GSK's Blenrep Combination Secures Priority Re...
Benzinga Newsdesk
Oracle, Vertiv And A Health Care Stock On CNBC's 'Final Trades'
Avi Kapoor
The FDA Has Accepted For Review GSK's Nucala ...
Benzinga Newsdesk
Friday, December 06, 2024
CNBC Halftime Report Final Trades: Oracle, Ve...
Benzinga Newsdesk
Reuters Agriculture & Energy Policy Reporter ...
Benzinga Newsdesk
Wednesday, November 27, 2024
GSK's Fully Liquid Menveo Meningococcal Vacci...
Benzinga Newsdesk
Tuesday, November 26, 2024
Bird Flu Found In Raw Milk Leads To Recall In California
Erica Kollmann
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
Vandana Singh
Wednesday, November 20, 2024
Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?
Hayden Buckfire
Show More
